Key Insights

Highlights

Success Rate

76% trial completion

Published Results

39 trials with published results (19%)

Research Maturity

87 completed trials (42% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

13.4%

28 terminated out of 209 trials

Success Rate

75.7%

-10.9% vs benchmark

Late-Stage Pipeline

11%

22 trials in Phase 3/4

Results Transparency

45%

39 of 87 completed with results

Key Signals

39 with results76% success28 terminated

Data Visualizations

Phase Distribution

143Total
Not Applicable (71)
Early P 1 (2)
P 1 (16)
P 2 (32)
P 3 (13)
P 4 (9)

Trial Status

Completed87
Recruiting36
Terminated28
Unknown27
Withdrawn14
Active Not Recruiting7

Trial Success Rate

75.7%

Benchmark: 86.5%

Based on 87 completed trials

Clinical Trials (209)

Showing 20 of 20 trials
NCT07556237Not ApplicableNot Yet RecruitingPrimary

Gastric Electrical Stimulation for Abdominal Pain in Patients With Gastroparesis

NCT07526935Not ApplicableActive Not RecruitingPrimary

Combined Role of Gastric Peroral Endoscopic Myotomy and Gastric Electrical Stimulator

NCT06783504Not ApplicableNot Yet Recruiting

Effect Of Percutaneous Electrical Nerve Field Stimulation on Symptom Control/Nervous System Activity in Patients w/Diabetes Types 1/2

NCT05004012Not ApplicableCompletedPrimary

Magnetically Controlled Capsule Endoscopy Feasibility Study in Gastric Motility

NCT05812339Enrolling By Invitation

Body Surface Gastric Mapping to Evaluate Patients With Upper Gastrointestinal Symptoms and Controls

NCT06732453Not ApplicableRecruiting

Brain-Gut Yoga for Functional Dyspepsia and Gastroparesis (FD-GP)

NCT03876288RecruitingPrimary

Gastroparesis Outcome Longitudinal Database Enrolled Numerically

NCT03011151CompletedPrimary

Protease Activated Receptor-2 and Gastrointestinal Dysfunction in Critical Illness

NCT06803589Early Phase 1RecruitingPrimary

Growth Hormone for the Treatment of Gastroparesis

NCT05621811Phase 2CompletedPrimary

Different Doses of Naronapride vs. Placebo in Gastroparesis

NCT01696734Phase 3Recruiting

Domperidone in Treating Patients With Gastrointestinal Disorders

NCT05229432Recruiting

Study of Gastric Motility in Eosinophilic Gastritis

NCT04026997Phase 2TerminatedPrimary

A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis

NCT04699591Not ApplicableRecruiting

Compassionate Use of Domperidone for Refractory Gastroparesis

NCT06738628Not Yet Recruiting

Disposable Endoscope Platform in Third Space Endoscopic Procedures

NCT07474415Not ApplicableCompletedPrimary

Controlled Trial of Gastric Electrical Stimulation in Children

NCT07104214Recruiting

Development and Validation of a Risk Prediction Model for Gastric Retention in Patients Undergoing Sedated Gastroscopy

NCT04207996Active Not RecruitingPrimary

Vagus Nerve Response in Gastroparesis Patients

NCT02159586Active Not RecruitingPrimary

Cardiac Vagal Effects of GES in Patients With Gastroparesis and Vagal Nerve Action Potentials in Vagus Nerve

NCT05079568Not ApplicableSuspendedPrimary

A Study to Evaluate the Safety and Tolerability of Virtual Reality to Treat Gastroparesis

Scroll to load more

Research Network

Activity Timeline